Literature DB >> 24790750

Successful management of a neglected case of nephropathic cystinosis.

Mohamed A El-Naggari1, Ibtisam Elnour1, Hussein Al-Kindy1, Aamir Al-Shahrabally1, Anas A Abdelmogheth1.   

Abstract

Cystinosis is a rare metabolic disorder characterised by lysosomal cystine accumulation leading to multi-organ damage; clinically, the kidneys are the first organ affected. Respiratory insufficiency caused by overall respiratory muscle myopathy is a life-threatening complication. Treatment with cysteamine should be initiated rapidly and continued lifelong to prolong renal function and protect the extra-renal organs. We report the case of a four-year-old Omani girl, diagnosed with infantile nephropathic cystinosis at 21 months. Cysteamine was prescribed but with no compliance to medications. She presented to the Child Health Department of Sultan Qaboos University Hospital, Oman, two years later with severe failure to thrive, electrolyte disturbance and respiratory failure. The hypoventilation and early respiratory dysfunction, due to intercostal and diaphragm myopathy, was treated by non-invasive positive-pressure ventilation. The patient was discharged after four months of intensive rehabilitation with no ventilator support. No standard treatment options have yet been established for respiratory dysfunction in cystinosis.

Entities:  

Keywords:  Case Report; Continuous Positive Airway Pressure; Cysteamine; Cystinosis; Failure to Thrive; Oman; Pediatric Intensive Care Units; Positive-Pressure Ventilation

Year:  2014        PMID: 24790750      PMCID: PMC3997544     

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  10 in total

Review 1.  Cystinosis.

Authors:  William A Gahl; Jess G Thoene; Jerry A Schneider
Journal:  N Engl J Med       Date:  2002-07-11       Impact factor: 91.245

2.  Long-term follow-up of well-treated nephropathic cystinosis patients.

Authors:  Robert Kleta; Isa Bernardini; Masako Ueda; William S Varade; Chanika Phornphutkul; Donna Krasnewich; William A Gahl
Journal:  J Pediatr       Date:  2004-10       Impact factor: 4.406

3.  Successful treatment of respiratory dysfunction in cystinosis by nocturnal non-invasive positive pressure ventilation.

Authors:  M A Edens; W J van Son; M H G de Greef; E N Levtchenko; T Blijham; P J Wijkstra
Journal:  Clin Nephrol       Date:  2006-10       Impact factor: 0.975

4.  Myopathy and cystine storage in muscles in a patient with nephropathic cystinosis.

Authors:  W A Gahl; M C Dalakas; L Charnas; K T Chen; G H Pezeshkpour; T Kuwabara; S L Davis; R W Chesney; J Fink; H T Hutchison
Journal:  N Engl J Med       Date:  1988-12-01       Impact factor: 91.245

5.  Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapy.

Authors:  Adrien Jézégou; Elisa Llinares; Christine Anne; Sylvie Kieffer-Jaquinod; Seana O'Regan; Joëlle Aupetit; Allel Chabli; Corinne Sagné; Cécile Debacker; Bernadette Chadefaux-Vekemans; Agnès Journet; Bruno André; Bruno Gasnier
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-20       Impact factor: 11.205

6.  Nephropathic Cystinosis: First reported case in Oman.

Authors:  Dana Al-Nabhani; Mohammed El-Naggari; Rana Al-Sinawi; Alexander P Chacko; Anuradha Ganesh; Ibtisam El Nour
Journal:  Sultan Qaboos Univ Med J       Date:  2011-10-25

7.  A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis.

Authors:  M Town; G Jean; S Cherqui; M Attard; L Forestier; S A Whitmore; D F Callen; O Gribouval; M Broyer; G P Bates; W van't Hoff; C Antignac
Journal:  Nat Genet       Date:  1998-04       Impact factor: 38.330

8.  Pulmonary dysfunction in adults with nephropathic cystinosis.

Authors:  Y Anikster; F Lacbawan; M Brantly; B L Gochuico; N A Avila; W Travis; W A Gahl
Journal:  Chest       Date:  2001-02       Impact factor: 9.410

9.  Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis.

Authors:  V E Kimonis; J Troendle; S R Rose; M L Yang; T C Markello; W A Gahl
Journal:  J Clin Endocrinol Metab       Date:  1995-11       Impact factor: 5.958

10.  Distal vacuolar myopathy in nephropathic cystinosis.

Authors:  L R Charnas; C A Luciano; M Dalakas; R W Gilliatt; I Bernardini; K Ishak; V A Cwik; D Fraker; T A Brushart; W A Gahl
Journal:  Ann Neurol       Date:  1994-02       Impact factor: 10.422

  10 in total
  2 in total

1.  Nephropathic Cystinosis Presenting as Renal Fanconi Syndrome without Glycosuria.

Authors:  Jayashree Kanthila; Smitha Dsa; Kamalakshi G Bhat
Journal:  J Clin Diagn Res       Date:  2015-03-01

2.  Worldwide view of nephropathic cystinosis: results from a survey from 30 countries.

Authors:  Aurélia Bertholet-Thomas; Julien Berthiller; Velibor Tasic; Behrouz Kassai; Hasan Otukesh; Marcella Greco; Jochen Ehrich; Rejane de Paula Bernardes; Georges Deschênes; Sally-Ann Hulton; Michel Fischbach; Kenza Soulami; Bassam Saeed; Ehsan Valavi; Carlos Jose Cobenas; Bülent Hacihamdioglu; Gabrielle Weiler; Pierre Cochat; Justine Bacchetta
Journal:  BMC Nephrol       Date:  2017-07-03       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.